Cargando…

Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort

INTRODUCTION: Given the lack of data, we aimed to assess the impact of the length of diagnostic delay on the natural history of ulcerative colitis (UC) in pediatric (diagnosed <18 years) and adult patients (diagnosed ≥18 years). METHODS: Data from the Swiss Inflammatory Bowel Disease Cohort Study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoepfer, Alain M., Tran, Vu Dang Chau, Rossel, Jean-Benoit, Sokollik, Christiane, Spalinger, Johannes, Safroneeva, Ekaterina, von Graffenried, Thea, Godat, Sébastien, Hahnloser, Dieter, Vavricka, Stephan R., Braegger, Christian, Nydegger, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294935/ https://www.ncbi.nlm.nih.gov/pubmed/35979190 http://dx.doi.org/10.1159/000520995

Ejemplares similares

Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
por: von Graffenried, Thea, et al.
Publicado: (2022)

Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study
por: Safroneeva, Ekaterina, et al.
Publicado: (2015)

Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients
por: Salzmann, Medea, et al.
Publicado: (2022)

Gender Differences in Paediatric Patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Herzog, Denise, et al.
Publicado: (2014)

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)

Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014
por: Bähler, Caroline, et al.
Publicado: (2017)

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
por: Spalinger, Marianne R., et al.
Publicado: (2016)

Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
por: Bon, Lorenz, et al.
Publicado: (2019)

Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study
por: Schüle, Solvey, et al.
Publicado: (2017)

The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
por: Yilmaz, Bahtiyar, et al.
Publicado: (2018)

PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease
por: Horn, Michael P., et al.
Publicado: (2018)

Elective Surgery for Diverticulitis in Swiss Hospitals
por: Faes, Seraina, et al.
Publicado: (2021)

Assessing the Clinical and Endoscopic Efficacy of Extended Treatment Duration with Different Doses of Mesalazine for Mild-to-Moderate Ulcerative Colitis beyond 8 Weeks of Induction
por: D’Haens, Geert, et al.
Publicado: (2023)

Atypical hematological manifestation of celiac disease: A case report of aplastic anemia in a 2‐year‐old child and review of the literature
por: von Graffenried, Thea, et al.
Publicado: (2021)

Close follow‐up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long‐term management of eosinophilic esophagitis
por: Bon, Lorenz, et al.
Publicado: (2022)

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Biedermann, Luc, et al.
Publicado: (2019)

Molecular and Histological Profiling Reveals an Innate-Shaped Immune Microenvironment in Solitary Juvenile Polyps
por: Zysset, Daniel, et al.
Publicado: (2021)

Effect of closed and permanent stoma on disease course, psychological well-being and working capacity in Swiss IBD cohort study patients
por: Bianchi, Rahel, et al.
Publicado: (2022)

Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
por: Pugliese, Daniela, et al.
Publicado: (2021)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC)
por: Jentzer, Alexandre, et al.
Publicado: (2020)

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
por: Bamias, Giorgos, et al.
Publicado: (2021)

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study
por: Lautenschlager, Severin A., et al.
Publicado: (2023)

Endoscopic ultrasound-guided hepaticogastrostomy drainage of an excluded left hepatic lobe in a hybrid way with percutaneous assistance
por: Moschouri, Eleni, et al.
Publicado: (2017)

Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling
por: Sipos, Ferenc, et al.
Publicado: (2011)

Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children
por: Martin, Francois-Pierre, et al.
Publicado: (2017)

Risk factors for complications in patients with ulcerative colitis
por: Manser, Christine N, et al.
Publicado: (2016)

Innovative Makeshift Technique for Removing Ingested Rare Earth Magnets
por: Guilcher, Katharina, et al.
Publicado: (2022)

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account
por: Zeitz, Jonas, et al.
Publicado: (2016)

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020)

Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland
por: Perrig, Kathrin, et al.
Publicado: (2022)

Validation of the ‘Inflammatory Bowel Disease—Distribution, Chronicity, Activity [IBD-DCA] Score’ for Ulcerative Colitis and Crohn´s Disease
por: Lang-Schwarz, Corinna, et al.
Publicado: (2021)

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
por: Hong, Simon J, et al.
Publicado: (2021)

Determinants of new drugs prescription in the Swiss healthcare market
por: Decollogny, Anne, et al.
Publicado: (2018)

Determinants of drug expenditure in the Swiss healthcare market in 2006
por: Eggli, Yves, et al.
Publicado: (2022)

Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study
por: Bähler, Caroline, et al.
Publicado: (2022)

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Macrophage and dendritic cell subsets in IBD: ALDH(+) cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation
por: Magnusson, Maria K, et al.
Publicado: (2015)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
por: Fagagnini, Stefania, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u4lt27f3i8n0qb4145692abf0b